Endobronchial Valves for Bronchoscopic Lung Volume Reduction in Severe Emphysema: A Reversible and Non-Surgical Treatment for Patients Who May or May Not Be Candidates for Lung Transplantation.

Mateus Fernandes, David Eldeiry, Ali Musani

Abstract readReview

In one paragraph

Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mateus FernandesDepartment of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Lenox Hill Hospital, Northwell Health, New York, NY 10075, USA.ORCID 0000-0002-2367-4038

David EldeiryDepartment of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Lenox Hill Hospital, Northwell Health, New York, NY 10075, USA.

Ali MusaniDepartment of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Lenox Hill Hospital, Northwell Health, New York, NY 10075, USA.ORCID 0009-0005-4419-6492

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease remains a leading cause of death worldwide, with emphysema contributing significantly to dyspnea, exercise limitation, and mortality. Bronchoscopic lung volume reduction (BLVR) using endobronchial valves (EBVs) has emerged as a minimally invasive, reversible alternative to lung volume reduction surgery for carefully selected patients with severe emphysema who remain symptomatic despite optimal medical therapy. EBVs are one-way valves placed bronchoscopically to achieve complete lobar occlusion, inducing atelectasis of the most diseased lung segments while allowing better ventilated parenchyma to expand, thereby improving respiratory mechanics and reducing hyperinflation. Landmark randomized controlled trials demonstrated that BLVR using EBVs produces significant improvements in forced expiratory volume in one second (FEV

Indexed as

bronchoscopic lung volume reductionchronic obstructive lung diseaseemphysemaendobronchial valve

Identifiers

PMID42279507

DOI10.3390/diagnostics16111639

PMCPMC13256581

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.